1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUCrenal pelvis/ureter urothelial carcinomaRecruitingPhase 22026-08-03NCT07741448